Drug Type AAV based gene therapy |
Synonyms |
Target- |
Mechanism Gene transference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Nanoscope Therapeutics, Inc.Startup |
Active Organization Nanoscope Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Wet age-related macular degeneration | Preclinical | US | Nanoscope Therapeutics, Inc.Startup | 10 Jan 2022 |